Josh Feng portrait
  • Assistant Professor, Department of Entrepreneurship and Strategy

Presentations

  • Jiashuo Feng, & Thomas Hwang, Yunjuan Liu, and Luca Maini. (2023) Mergers that Matter: the Impact of M&A Activity in Prescription Drug Markets. Invited Talk/Keynote, Presented, 11/02/2023.
  • Jiashuo Feng, & Elias Einio, Xavier Jaravel. (2023) Social Push and the Direction of Innovation. Invited Talk/Keynote, Presented, 04/05/2023.
  • Josh Feng, & Xavier Jaravel, Elias Einio. (2020) Social Push and the Direction of Innovation. Invited Talk/Keynote, Presented, 11/10/2020.
  • Josh Feng, & Xavier Jaravel, Elias Einio. (2020) Social Push and the Direction of Innovation. Conference Paper, Presented, 10/29/2020.
  • Josh Feng, & Xavier Jaravel, Elias Einio. (2020) Social Push and the Direction of Innovation. Invited Talk/Keynote, Presented, 07/16/2020.
  • Josh Feng, & Xavier Jaravel, Elias Einio. (2020) Social Push and the Direction of Innovation. Conference Paper, Presented, 01/04/2020.
  • Josh Feng (2019) Pricing Intermediaries in Prescription Drug Markets. Invited Talk/Keynote, Presented, 10/17/2019.
  • Josh Feng, & Xavier Jaravel. (2019) Innovating for People Like Me. Conference Paper, Presented, 09/19/2019.
  • Josh Feng (2019) Pricing Intermediaries in Prescription Drug Markets. Conference Paper, Presented, 06/21/2019.

Grants, Contracts & Research Gifts

Publications

  • Josh Feng & Luca Maini (2023). Demand Inertia and the Hidden Impact of Pharmacy Benefit Managers. Management Science. Accepted, 07/31/2023.
  • Thomas Hwang, Josh Feng, Luca Maini & Aaron Kesselheim (2022). Medicaid Expenditures and Estimated Rebates on Line Extension Drugs, 2010--2018. Journal of General Internal Medicine. Published, 02/22/2022.
  • Josh Feng, Thomas Hwang & Luca Maini (2022). Profiting from Most-Favored Customer Procurement Rules: Evidence from Medicaid. American Economic Journal: Economic Policy. Accepted, 02/01/2022.
  • Josh Feng (2021). History-Dependence in Drug Demand: Identification and Implications for Entry Incentives. Review of Economics and Statistics. Accepted, 11/29/2021.
  • Josh Feng & Xavier Jaravel (2020). Crafting Intellectual Property Rights: Implications for Patent Assertion Entities, Litigation, and Innovation. American Economic Journal: Applied Economics. Published, 01/01/2020.
  • Thomas Hwang, Stacie Dusetzina, Josh Feng, Luca Maini & Aaron Kesselheim (2019). Price Increases of Protected-Class Drugs in Medicare Part D, Relative to Inflation, 2012-2017. JAMA. Published, 07/16/2019.